Cubist Systematic Strategies LLC Takes $5.28 Million Position in Encompass Health Co. (NYSE:EHC)

Cubist Systematic Strategies LLC bought a new position in shares of Encompass Health Co. (NYSE:EHC - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 57,215 shares of the company's stock, valued at approximately $5,284,000. Cubist Systematic Strategies LLC owned about 0.06% of Encompass Health at the end of the most recent quarter.

Other institutional investors have also modified their holdings of the company. MassMutual Private Wealth & Trust FSB increased its holdings in shares of Encompass Health by 87.8% in the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 293 shares of the company's stock valued at $27,000 after purchasing an additional 137 shares in the last quarter. Transce3nd LLC purchased a new position in Encompass Health in the fourth quarter valued at about $40,000. CBIZ Investment Advisory Services LLC lifted its position in shares of Encompass Health by 38.7% during the 4th quarter. CBIZ Investment Advisory Services LLC now owns 455 shares of the company's stock valued at $42,000 after acquiring an additional 127 shares during the period. Tompkins Financial Corp purchased a new stake in shares of Encompass Health during the 4th quarter worth approximately $46,000. Finally, V Square Quantitative Management LLC increased its stake in Encompass Health by 43.8% in the 4th quarter. V Square Quantitative Management LLC now owns 581 shares of the company's stock valued at $54,000 after purchasing an additional 177 shares in the last quarter. 97.25% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at Encompass Health

In other news, EVP John Patrick Darby sold 10,000 shares of the stock in a transaction dated Tuesday, April 29th. The stock was sold at an average price of $114.79, for a total transaction of $1,147,900.00. Following the transaction, the executive vice president now owns 79,710 shares of the company's stock, valued at approximately $9,149,910.90. This represents a 11.15% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider Elissa Joy Charbonneau sold 4,279 shares of the stock in a transaction that occurred on Tuesday, May 6th. The shares were sold at an average price of $116.61, for a total value of $498,974.19. Following the transaction, the insider now owns 11,958 shares in the company, valued at approximately $1,394,422.38. This trade represents a 26.35% decrease in their position. The disclosure for this sale can be found here. Insiders sold 19,321 shares of company stock valued at $2,142,452 over the last three months. 2.00% of the stock is owned by corporate insiders.

Encompass Health Price Performance

Encompass Health stock traded up $0.96 during trading hours on Tuesday, hitting $117.89. 604,840 shares of the company traded hands, compared to its average volume of 686,927. Encompass Health Co. has a 1-year low of $82.74 and a 1-year high of $118.27. The firm has a market cap of $11.88 billion, a P/E ratio of 26.43, a P/E/G ratio of 2.31 and a beta of 0.91. The firm's 50-day simple moving average is $103.77 and its two-hundred day simple moving average is $100.16. The company has a quick ratio of 1.04, a current ratio of 1.05 and a debt-to-equity ratio of 0.84.

Encompass Health (NYSE:EHC - Get Free Report) last announced its quarterly earnings data on Thursday, April 24th. The company reported $1.37 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.19 by $0.18. Encompass Health had a net margin of 8.48% and a return on equity of 17.56%. The company had revenue of $1.46 billion for the quarter, compared to analysts' expectations of $1.43 billion. During the same quarter in the previous year, the company posted $1.12 EPS. The business's revenue was up 10.6% compared to the same quarter last year. As a group, analysts forecast that Encompass Health Co. will post 4.8 earnings per share for the current fiscal year.

Encompass Health Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, July 15th. Stockholders of record on Tuesday, July 1st will be issued a $0.17 dividend. The ex-dividend date of this dividend is Tuesday, July 1st. This represents a $0.68 dividend on an annualized basis and a dividend yield of 0.58%. Encompass Health's dividend payout ratio is 14.05%.

Analyst Ratings Changes

Several research firms have weighed in on EHC. StockNews.com upgraded shares of Encompass Health from a "hold" rating to a "buy" rating in a report on Sunday. Royal Bank of Canada raised their price objective on shares of Encompass Health from $110.00 to $125.00 and gave the stock an "outperform" rating in a research note on Monday, April 28th. KeyCorp upped their target price on Encompass Health from $120.00 to $122.00 and gave the company an "overweight" rating in a research note on Friday, April 25th. UBS Group raised their price target on Encompass Health from $117.00 to $130.00 and gave the stock a "buy" rating in a research report on Monday, April 28th. Finally, Barclays upped their price objective on Encompass Health from $118.00 to $129.00 and gave the company an "overweight" rating in a research report on Friday, April 25th. Nine equities research analysts have rated the stock with a buy rating and one has given a strong buy rating to the company's stock. According to MarketBeat.com, the company currently has a consensus rating of "Buy" and an average target price of $120.86.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.